FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047072783> ?p ?o ?g. }

• W2047072783 endingPage "245" @default.
• W2047072783 startingPage "241" @default.
• W2047072783 abstract "Response to treatment with imatinib mesylate has been associated in preclinical models with the inhibition of two signaling pathways that promote cellular survival – the phosphatidylinositol 3-kinase/AKT pathway and the mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) pathway. We sought to evaluate the extent of inhibition of these two pathways in metastatic melanoma specimens from patients treated with imatinib. Metastatic melanoma tumor samples were obtained before and during the second week of imatinib treatment from patients enrolled in a phase II study. A tissue microarray was constructed using formalin-fixed, paraffin-embedded tissues, and immunohistochemical analysis was performed using standard techniques to detect phosphorylated (p) ERK1/2 and pAKT expression. Of 21 patients who were treated with imatinib, tumor samples adequate for analysis were available both at baseline and during the second week of treatment from 10 patients for pERK1/2 expression and from nine patients for pAKT expression. No consistent pattern of change in pAKT or pERK expression after treatment with imatinib was observed. No apparent correlation between the clinical benefit of imatinib treatment and changes in pAKT and pERK1/2 expression was observed. A better understanding of the AKT and mitogen-activated protein kinase pathways is needed to optimize the clinical benefit of targeted therapy, such as imatinib." @default.
• W2047072783 created "2016-06-24" @default.
• W2047072783 creator A5008223341 @default.
• W2047072783 creator A5013973767 @default.
• W2047072783 creator A5015498468 @default.
• W2047072783 creator A5026562050 @default.
• W2047072783 creator A5033798832 @default.
• W2047072783 creator A5056145772 @default.
• W2047072783 creator A5057077121 @default.
• W2047072783 creator A5060332161 @default.
• W2047072783 creator A5069637890 @default.
• W2047072783 creator A5077153113 @default.
• W2047072783 creator A5087156478 @default.
• W2047072783 creator A5087385450 @default.
• W2047072783 date "2008-08-01" @default.
• W2047072783 modified "2023-10-17" @default.
• W2047072783 title "Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment" @default.
• W2047072783 cites W1977983659 @default.
• W2047072783 cites W1992734097 @default.
• W2047072783 cites W1996017770 @default.
• W2047072783 cites W2015682571 @default.
• W2047072783 cites W2060317877 @default.
• W2047072783 cites W2079592710 @default.
• W2047072783 cites W2093114816 @default.
• W2047072783 cites W2129318139 @default.
• W2047072783 cites W2139248078 @default.
• W2047072783 cites W2150099075 @default.
• W2047072783 cites W2161724145 @default.
• W2047072783 cites W2163188200 @default.
• W2047072783 cites W2321645860 @default.
• W2047072783 doi "https://doi.org/10.1097/cmr.0b013e3283046146" @default.
• W2047072783 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3880193" @default.
• W2047072783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18626307" @default.
• W2047072783 hasPublicationYear "2008" @default.
• W2047072783 type Work @default.
• W2047072783 sameAs 2047072783 @default.
• W2047072783 citedByCount "5" @default.
• W2047072783 countsByYear W20470727832015 @default.
• W2047072783 countsByYear W20470727832017 @default.
• W2047072783 countsByYear W20470727832020 @default.
• W2047072783 crossrefType "journal-article" @default.
• W2047072783 hasAuthorship W2047072783A5008223341 @default.
• W2047072783 hasAuthorship W2047072783A5013973767 @default.
• W2047072783 hasAuthorship W2047072783A5015498468 @default.
• W2047072783 hasAuthorship W2047072783A5026562050 @default.
• W2047072783 hasAuthorship W2047072783A5033798832 @default.
• W2047072783 hasAuthorship W2047072783A5056145772 @default.
• W2047072783 hasAuthorship W2047072783A5057077121 @default.
• W2047072783 hasAuthorship W2047072783A5060332161 @default.
• W2047072783 hasAuthorship W2047072783A5069637890 @default.
• W2047072783 hasAuthorship W2047072783A5077153113 @default.
• W2047072783 hasAuthorship W2047072783A5087156478 @default.
• W2047072783 hasAuthorship W2047072783A5087385450 @default.
• W2047072783 hasBestOaLocation W20470727832 @default.
• W2047072783 hasConcept C126322002 @default.
• W2047072783 hasConcept C143998085 @default.
• W2047072783 hasConcept C184235292 @default.
• W2047072783 hasConcept C204232928 @default.
• W2047072783 hasConcept C2777583451 @default.
• W2047072783 hasConcept C2777658100 @default.
• W2047072783 hasConcept C2778729363 @default.
• W2047072783 hasConcept C3019892230 @default.
• W2047072783 hasConcept C502942594 @default.
• W2047072783 hasConcept C57074206 @default.
• W2047072783 hasConcept C62478195 @default.
• W2047072783 hasConcept C71924100 @default.
• W2047072783 hasConcept C75217442 @default.
• W2047072783 hasConcept C86803240 @default.
• W2047072783 hasConcept C95444343 @default.
• W2047072783 hasConceptScore W2047072783C126322002 @default.
• W2047072783 hasConceptScore W2047072783C143998085 @default.
• W2047072783 hasConceptScore W2047072783C184235292 @default.
• W2047072783 hasConceptScore W2047072783C204232928 @default.
• W2047072783 hasConceptScore W2047072783C2777583451 @default.
• W2047072783 hasConceptScore W2047072783C2777658100 @default.
• W2047072783 hasConceptScore W2047072783C2778729363 @default.
• W2047072783 hasConceptScore W2047072783C3019892230 @default.
• W2047072783 hasConceptScore W2047072783C502942594 @default.
• W2047072783 hasConceptScore W2047072783C57074206 @default.
• W2047072783 hasConceptScore W2047072783C62478195 @default.
• W2047072783 hasConceptScore W2047072783C71924100 @default.
• W2047072783 hasConceptScore W2047072783C75217442 @default.
• W2047072783 hasConceptScore W2047072783C86803240 @default.
• W2047072783 hasConceptScore W2047072783C95444343 @default.
• W2047072783 hasIssue "4" @default.
• W2047072783 hasLocation W20470727831 @default.
• W2047072783 hasLocation W20470727832 @default.
• W2047072783 hasLocation W20470727833 @default.
• W2047072783 hasLocation W20470727834 @default.
• W2047072783 hasOpenAccess W2047072783 @default.
• W2047072783 hasPrimaryLocation W20470727831 @default.
• W2047072783 hasRelatedWork W128422138 @default.
• W2047072783 hasRelatedWork W1968814687 @default.
• W2047072783 hasRelatedWork W2284964826 @default.
• W2047072783 hasRelatedWork W2328771497 @default.
• W2047072783 hasRelatedWork W2401574182 @default.
• W2047072783 hasRelatedWork W2947099994 @default.
• W2047072783 hasRelatedWork W3129743340 @default.

• next